From November 5, 2021 to December 31, 2021, the company has repurchased 248,700 shares, representing 0.65% for ¥841.01 million. With this, the company has completed the repurchase of 248,700 shares, representing 0.65% for ¥841.01 million under the buyback announced on November 5, 2021.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
3,070 JPY | +1.32% | +5.07% | -6.12% |
04-25 | Hidehiro Imatsu named president of Goldman Sachs Japan | RE |
03-21 | Tranche Update on Mochida Pharmaceutical Co., Ltd.'s Equity Buyback Plan announced on May 15, 2023. | CI |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-6.12% | 682M | |
+51.63% | 796B | |
+41.51% | 628B | |
-5.10% | 358B | |
+19.90% | 331B | |
+9.95% | 301B | |
+17.66% | 244B | |
+3.39% | 228B | |
+10.75% | 214B | |
+6.99% | 165B |
- Stock Market
- Equities
- 4534 Stock
- News Mochida Pharmaceutical Co., Ltd.
- Tranche Update on Mochida Pharmaceutical Co., Ltd.'s Equity Buyback Plan announced on November 5, 2021.